advertisement

WGC-2021

14 Costing studies; pharmacoeconomics (57)

Showing records 1 to 25

Display all abstracts in classification 14 Costing studies; pharmacoeconomics

Search within classification 14 Costing studies; pharmacoeconomics
80508 Evaluation of an Algorithm for Identifying Ocular Conditions in Electronic Health Record Data
Stein JD
JAMA ophthalmology 2019; 137: 491-497
81091 Systematic Review of Economic Evaluations in Primary Open-Angle Glaucoma: Decision Analytic Modeling Insights
Bartelt-Hofer J
PharmacoEconomics - open 2019; 0:
81033 Caregiver Burden in Primary Congenital Glaucoma
Kantipuly A
American Journal of Ophthalmology 2019; 205: 106-114
81466 Ophthalmic Care Utilization and Out-of-Pocket Expenditure in Iran: Kurdistan Eye Health and Economics Survey-2015
Mohammadi SF
Iranian journal of public health 2019; 48: 1301-1309
81057 Prevalence of treatment with glaucoma medication in Scotland, 2010-2017
Rotchford AP
British Journal of Ophthalmology 2019; 0:
80841 Overuse and Underuse of Visual Field Testing Over 15 Years
Ben-Artsi E
Journal of Glaucoma 2019; 28: 660-665
81123 Cost-effectiveness and cost-utility of population-based glaucoma screening in China: a decision-analytic Markov model
Tang J
The Lancet. Global health 2019; 7: e968-e978
81465 Dynamic Monitoring and Control of Irreversible Chronic Diseases with Application to Glaucoma
Kazemian P
Production and operations management 2019; 28: 1082-1107
80510 Epidemiological variations and trends in health burden of glaucoma worldwide
Wang W
Acta Ophthalmologica 2019; 97: e349-e355
80674 The Cost and Economics of Endoscopic Cyclophotocoagulation in the United Kingdom: A Tertiary Center Experience
Ho H
Journal of Glaucoma 2019; 28: 563-567
81033 Caregiver Burden in Primary Congenital Glaucoma
Pillai MR
American Journal of Ophthalmology 2019; 205: 106-114
80841 Overuse and Underuse of Visual Field Testing Over 15 Years
Goldenfeld M
Journal of Glaucoma 2019; 28: 660-665
81123 Cost-effectiveness and cost-utility of population-based glaucoma screening in China: a decision-analytic Markov model
Liang Y
The Lancet. Global health 2019; 7: e968-e978
80510 Epidemiological variations and trends in health burden of glaucoma worldwide
He M
Acta Ophthalmologica 2019; 97: e349-e355
81465 Dynamic Monitoring and Control of Irreversible Chronic Diseases with Application to Glaucoma
Helm JE
Production and operations management 2019; 28: 1082-1107
81466 Ophthalmic Care Utilization and Out-of-Pocket Expenditure in Iran: Kurdistan Eye Health and Economics Survey-2015
Alinia C
Iranian journal of public health 2019; 48: 1301-1309
80674 The Cost and Economics of Endoscopic Cyclophotocoagulation in the United Kingdom: A Tertiary Center Experience
Ho J
Journal of Glaucoma 2019; 28: 563-567
81057 Prevalence of treatment with glaucoma medication in Scotland, 2010-2017
Hughes J
British Journal of Ophthalmology 2019; 0:
80508 Evaluation of an Algorithm for Identifying Ocular Conditions in Electronic Health Record Data
Rahman M
JAMA ophthalmology 2019; 137: 491-497
81091 Systematic Review of Economic Evaluations in Primary Open-Angle Glaucoma: Decision Analytic Modeling Insights
Ben-Debba L
PharmacoEconomics - open 2019; 0:
80510 Epidemiological variations and trends in health burden of glaucoma worldwide
Li Z
Acta Ophthalmologica 2019; 97: e349-e355
81466 Ophthalmic Care Utilization and Out-of-Pocket Expenditure in Iran: Kurdistan Eye Health and Economics Survey-2015
Ghaderi E
Iranian journal of public health 2019; 48: 1301-1309
80841 Overuse and Underuse of Visual Field Testing Over 15 Years
Zehavi-Dorin T
Journal of Glaucoma 2019; 28: 660-665
81123 Cost-effectiveness and cost-utility of population-based glaucoma screening in China: a decision-analytic Markov model
O'Neill C
The Lancet. Global health 2019; 7: e968-e978
81057 Prevalence of treatment with glaucoma medication in Scotland, 2010-2017
Agarwal PK
British Journal of Ophthalmology 2019; 0:

Issue 20-3

Select Issue


advertisement

WGW-2021